Navigation Links
IntelliCell BioSciences Announces Research Agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey
Date:11/28/2012

NEW YORK, Nov. 28, 2012 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTCQB: SVFC)  announced today that it has entered a sponsored research agreement with the New Jersey Center for Biomaterials at Rutgers-The State University of New Jersey. 

Under terms of the agreement, the New Jersey Center for Biomaterials will be conducting a series of research projects that will further define the unique characteristics and properties of IntelliCell's proprietary cellular population. The work will be conducted on behalf of IntelliCell under the direction of Professor Joachim Kohn, the noted researcher and inventor who directs the New Jersey Center for Biomaterials.

Initial research will focus on documenting any differences between IntelliCell's proprietary cellular population and similar cell populations isolated from human adipose tissue using conventional methods of cell isolation.  After successful completion of the initial phases of the clinical research, the Company hopes to engage the New Jersey Center for Biomaterials in development projects that may lead to bioengineered products containing the proprietary IntelliCell cellular population and products under development at the New Jersey Center for Biomaterials.

Dr. Steven Victor, Chairman and CEO of IntelliCell stated, "We are very pleased to be working with Professor Kohn and the New Jersey Center for Biomaterials.  Our vision for the future includes a number of bio-applications whereby we can apply our technology to exciting new areas in regenerative medicine and work with top tier research institutions in the United States."

Professor Joachim Kohn, Director of the New Jersey Center for Biomaterials at Rutgers,-The State University of New Jersey added, "This is a truly exciting opportunity for us.  We have a number of highly advanced scaffolds for regenerative therapies (e.g. re-growing bone, nerve, and skin), and we expect that Intel
'/>"/>

SOURCE IntelliCell BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. IntelliCell BioSciences Signs Technology Licensing Agreement with Stem Cells 21 Thailand
2. IntelliCell BioSciences Expands Management Team
3. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
4. IntelliCell BioSciences Announces Myron Z. Holubiak Joins the IntelliCell BioSciences Board of Directors
5. IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London
6. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
7. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
10. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
11. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... (PRWEB) October 20, 2014 Convey ... that a team from Iowa State University won first ... contest. Using a Convey HC-2ex, the team’s solution achieved ... times faster than the second place finisher. , Experts ... embarked upon the month long challenge, using a variety ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
(Date:10/19/2014)... October 20, 2014 OCTOBER ... Meeting (ABIM). ABIM will take place ... information about ABIM 2014 is now available ... Delegates representing companies and organizations from all ... obtain information on the latest products and ...
(Date:10/19/2014)... 2014 The report "Chocolate, Cocoa Beans, ... Prices, Geography Trend and Forecast (2011 - 2016)," ... geography and studies the major market drivers, restraints, and ... and Asia. , The global chocolate market is expected ... in 2016 at an estimated CAGR of 2.7% from ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 2Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 3Chocolate Market Projected To Reach $98.3 Billion by 2016 - New Report by MarketsandMarkets 4
... BASEL, Switzerland, Dec. 5 Roche (SWX:,ROG.VX; RO.S) announced ... (Nasdaq: VMSI ), as required by Ventana,s bylaws, ... of directors at,Ventana,s 2008 annual stockholders meeting., On ... acquire all of the,outstanding common shares of Ventana for ...
... Cost, Savings and Avoidance of Approximately $1.5 Billion by 2010 and Incur, Associated ... ... 11% Increase in Indicative Dividend for 2008 and Declares ... Quarterly Dividend, * Revises 2007 Full-Year GAAP EPS Guidance to ...
... January for lead antibody program ... ... Inc. (TSX:,ARI), a biotechnology company discovering and developing the next wave of,antibody ... transfer agreement for its CD44 Cancer,Stem Cell antibody with Avid Bioservices, a ...
Cached Biology Technology:Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 2Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 3Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 4Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 5Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 6Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 7Roche to Nominate Independent Directors for Election at Ventana's 2008 Annual Stockholders Meeting 8Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 2Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 3Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 4Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 5Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 6Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 7Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 8Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 9Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 10Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community 11ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody 2ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody 3
(Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
(Date:10/16/2014)... new synthesis of recent research findings to inform their ... two states. , The Ecology and Management of ... Synthesis of the Relevant Biophysical Science and Implications for ... the U.S. Forest Service,s Pacific Northwest Research Station, is ... a synthesis of the large body of scientific information ...
(Date:10/16/2014)... efficiently, they are anything but sustainable: environmental damage ... is becoming increasingly evident. Despite their disadvantages, however, ... regarded as the sole possibility of achieving higher ... Bernhard Schmid, an ecology professor at the University ... agriculture and forestry. After all, a new study ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2New report synthesizes best available science on management of moist mixed-conifer forests 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3
... 16, 2013) A team of American and Chinese conservationists ... counted nearly 1,000 wild yaks from a remote area of ... this species, which was decimated by overhunting in the mid ... rugged area called Hoh Xil a national nature reserve ...
... 2013 Elsevier, a world-leading provider of scientific, technical ... announce the launch of a new journal, Journal ... ). JUOGR is to publish ... practices in the area of evaluation, development and management ...
... $14 million from the William & Nancy Thompson Family ... County, UC Irvine is helping lead the charge against ... in the U.S. autism., The funding created the ... which will provide unparalleled access to assessment, diagnosis, care ...
Cached Biology News:Yaks are back 2UCI research turns the corner on autism 2UCI research turns the corner on autism 3
CleanBox DNA workstation with two 254nm UV lambs & 12-hr timer, 90cm (36-inch)width, single door, 115V (w/crating)...
Mouse monoclonal antibody raised against a partial recombinant VRK2. NCBI Entrez Gene ID = VRK2...
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a partial recombinant L3MBTL2. NCBI Entrez Gene ID = L3MBTL2...
Biology Products: